In episode 10 of Hims House, Jonathan Stern, Louis Stevens, and Dr. H interview Sekander Amini, a UK-based pharmacist and long-time Hims investor. Sekander shares insights about how his pharmacy mirrors Hims' model by offering premium services like mental health and weight loss medications. He highlights Hims' advantages in compounding medications, simplifying treatment adherence, and leveraging technology for better patient care. The group discusses the healthcare landscape in the UK, touching on public versus private care and the potential growth opportunity for Hims. They also explore Hims' focus on premium experiences, the role of AI in healthcare, and what investors should watch for in the upcoming earnings call.
00:00 Introduction and Sekander Amino Welcome
00:52 Day-to-Day at the Private Pharmacy
03:24 Initial Investment in Hims
03:51 Hims' Price Transparency and Accessibility
05:46 Compounded Medications and Personalized Care
07:07 Premium Experience and Product Evolution
15:59 Comparing UK and US Healthcare Systems
20:53 Opportunities in the UK Market
23:09 Hims' Generic Offerings
23:30 UK Healthcare System Overview
24:19 Hims' Market Potential in the UK
24:48 Compounding Pharmacies in the UK
25:40 Challenges in International Expansion
27:10 Hims' Strategic Focus
34:18 MedMatch and Mental Health
40:14 International Expansion Concerns
44:09 Q3 Earnings Expectations
45:54 Closing Remarks and Farewell
Share this post